Arvinas (ARVN) Change in Account Payables (2017 - 2022)
Arvinas' (ARVN) quarterly Change in Account Payables came in at -$22.6 million in Q1 2022, down 1355.56% year-on-year from $1.8 million in Q1 2021, and down 186.17% quarter-over-quarter from $26.2 million in Q4 2021.
Arvinas (ARVN) Change in Account Payables (2017 - 2022) Analysis & Trends
Arvinas' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$22.6 million for Q1 2022.
- On a quarterly basis, Change in Account Payables fell 1355.56% year-over-year to -$22.6 million in Q1 2022; TTM through Mar 2022 was -$700000.0, a 112.26% decrease from a year earlier, with the FY2021 full-year figure at $23.7 million, up 1085.0% from the prior year.
- Change in Account Payables eased to -$22.6 million in Q1 2022 per ARVN's latest filing, from $26.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $26.2 million in Q4 2021 and bottomed at -$22.6 million in Q1 2022.
- The 5-year median for Change in Account Payables is $284784.0 (2019), against an average of $388362.5.
- Across the five-year window, Change in Account Payables surged 1067.29% in 2021 and tumbled 1355.56% in 2022, its largest moves.
- Year by year, Change in Account Payables stood at $1.3 million in 2018, then jumped by 63.26% to $2.1 million in 2019, then increased by 6.03% to $2.2 million in 2020, then jumped by 1067.29% to $26.2 million in 2021, then tumbled by 186.17% to -$22.6 million in 2022.
- Per Business Quant, the three latest ARVN Change in Account Payables figures stand at -$22.6 million (Q1 2022), $26.2 million (Q4 2021), and -$82863.0 (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -22.60 Mn |
| Mar 31, 2022 | -22.60 Mn |
| Dec 31, 2021 | 26.23 Mn |
| Dec 31, 2021 | 26.23 Mn |
| Sep 30, 2021 | -82,863.00 |
| Sep 30, 2021 | -82,863.00 |
| Jun 30, 2021 | -4.24 Mn |
| Jun 30, 2021 | -4.24 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 2.25 Mn |
| Dec 31, 2020 | 2.25 Mn |
| Sep 30, 2020 | 2.03 Mn |
| Sep 30, 2020 | 2.03 Mn |
| Jun 30, 2020 | -367,912.00 |
| Jun 30, 2020 | -367,912.00 |
| Mar 31, 2020 | -1.91 Mn |
| Mar 31, 2020 | -1.91 Mn |
| Dec 31, 2019 | 2.12 Mn |
| Dec 31, 2019 | 2.12 Mn |